AIDing cancer treatment: Reducing AID activity via HSP90 inhibition

E-ISSN： 1521-4141|45|8|2208-2211

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.45, Iss.8, 2015-08, pp. : 2208-2211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HSP90 inhibitors decrease AID levels and activity in mice and in human cells

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 8, 2015-08 ,pp. : 2365-2376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Enhancement of radiation sensitivity in lung cancer cells by celastrol is mediated by inhibition of Hsp90

International Journal of Molecular Medicine, Vol. 27, Iss. 3, 2011-01 ,pp. : 441-446

Spandidos Publications

Access to resources Recommend Favorite

Extracellular HSP90: An Emerging Target for Cancer Therapy

Current Signal Transduction Therapy, Vol. 4, Iss. 1, 2009-01 ,pp. : 51-58

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting multiple signal transduction pathways through inhibition of Hsp90

By Zhang Hong Burrows Francis

Journal of Molecular Medicine, Vol. 82, Iss. 8, 2004-08 ,pp. : 488-499

Springer Publishing Company

Access to resources Recommend Favorite

Ethoxyquin prevents chemotherapy‐induced neurotoxicity via Hsp90 modulation

ANNALS OF NEUROLOGY, Vol. 74, Iss. 6, 2013-12 ,pp. : 893-904

John Wiley & Sons Inc

Access to resources Recommend Favorite